[go: up one dir, main page]

AU5219798A - Gpi-ceruloplasmin, analogs thereof, and methods of use - Google Patents

Gpi-ceruloplasmin, analogs thereof, and methods of use

Info

Publication number
AU5219798A
AU5219798A AU52197/98A AU5219798A AU5219798A AU 5219798 A AU5219798 A AU 5219798A AU 52197/98 A AU52197/98 A AU 52197/98A AU 5219798 A AU5219798 A AU 5219798A AU 5219798 A AU5219798 A AU 5219798A
Authority
AU
Australia
Prior art keywords
ceruloplasmin
gpi
analogs
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU52197/98A
Inventor
Samuel David
Bharatkumar Patel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CA 2192407 external-priority patent/CA2192407A1/en
Application filed by Individual filed Critical Individual
Publication of AU5219798A publication Critical patent/AU5219798A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/8509—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0091—Oxidoreductases (1.) oxidizing metal ions (1.16)
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/07—Animals genetically altered by homologous recombination
    • A01K2217/075—Animals genetically altered by homologous recombination inducing loss of function, i.e. knock out
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00—Animals characterised by species
    • A01K2227/10—Mammal
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/03—Animal model, e.g. for test or diseases
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU52197/98A 1996-12-09 1997-12-09 Gpi-ceruloplasmin, analogs thereof, and methods of use Abandoned AU5219798A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
CA2192407 1996-12-09
CA 2192407 CA2192407A1 (en) 1996-12-09 1996-12-09 Ceruloplasmin analogs and methods of use
PCT/CA1997/000942 WO1998025954A2 (en) 1996-12-09 1997-12-09 Gpi-ceruloplasmin, analogs thereof, and methods of use
CA2218200 1997-12-09
CA 2218200 CA2218200A1 (en) 1996-12-09 1997-12-09 Gpi-ceruloplasmin, analogs thereof, and methods of use

Publications (1)

Publication Number Publication Date
AU5219798A true AU5219798A (en) 1998-07-03

Family

ID=25678902

Family Applications (1)

Application Number Title Priority Date Filing Date
AU52197/98A Abandoned AU5219798A (en) 1996-12-09 1997-12-09 Gpi-ceruloplasmin, analogs thereof, and methods of use

Country Status (3)

Country Link
AU (1) AU5219798A (en)
CA (1) CA2218200A1 (en)
WO (1) WO1998025954A2 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2270853A1 (en) 1999-05-05 2000-11-05 Unknown Ceruloplasmin and antioxidant compositions comprising the same and their uses as neuroprotective agent
CA2307475A1 (en) * 2000-05-03 2001-11-03 Universite Du Quebec A Montreal Ceruloplasmin and uses thereof in neurodegenerative related conditions
AU2002219046A1 (en) * 2000-10-24 2002-05-06 Bayer Aktiengesellschaft Regulation of human ceruloplasmin-like protein
WO2013091008A1 (en) * 2011-12-20 2013-06-27 The Mental Health Research Institute Of Victoria Method of treating reduced ceruloplasmin functionality in the central nervous system
BR122020013811A8 (en) * 2013-06-20 2022-08-30 Baxalta GmbH APPARATUS TO PROVIDE A THERAPEUTIC PLASMA PROTEIN DOSAGE SCHEME
CN110464833A (en) * 2019-09-04 2019-11-19 北京豪思生物科技有限公司 The application of ceruloplasmin

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69322847T2 (en) * 1993-01-13 1999-05-27 Idemitsu Kosan Co. Ltd., Tokio/Tokyo Monoclonal antibody against human ceruloplasmin

Also Published As

Publication number Publication date
WO1998025954A3 (en) 1998-08-27
WO1998025954A2 (en) 1998-06-18
CA2218200A1 (en) 1998-06-09

Similar Documents

Publication Publication Date Title
AU4597297A (en) Trans-sodium crocetinate, methods of making and methods of use thereof
AUPN864296A0 (en) Descender
AU5752398A (en) Novel ketobenzamides and their use
AU4261697A (en) Compounds and methods
AU1245297A (en) Preparation of 1,1,1,3,3-pentachlorobutane and 1,1,1,3,3-pentafluorobutane
AU4329396A (en) Use of 3,4-diphenylchromans
AU5383498A (en) Human chemokine beta-13
AU7095296A (en) Phosphorylamides, their preparation and use
AU3552697A (en) Novel treatment of leptine resistance
AU5923998A (en) 2-benzoylamino-3-phenylpropenamide derivatives and methods of using the same
AU5168496A (en) Butyryl-tyrosinyl spermine, analogs thereof and methods of preparing and using same
AU4224096A (en) Use of phenylcyclohexylcarboxamides
AUPN943096A0 (en) Descender
AU9569998A (en) Photo-spectrometers, methods of use and manufacture
AU3118297A (en) Sok-1 and methods of use
AU4328497A (en) Naphthyl compounds, intermediates, compositions, and methods of use
AU3241895A (en) Apoptosis related protein bcl-y, and methods of use thereof
AU1841195A (en) 1-beta -methyl-carbapenem, compositions containing same and methods of use
AU3467697A (en) 3'-oximino-2',3'-dideoxynucleosides and derivatives of the same
AU2030197A (en) 2-aminoethyl-benzofuran derivatives, preparation thereof and therapeutical use thereof
AU3200197A (en) New composition and methods
AU5219798A (en) Gpi-ceruloplasmin, analogs thereof, and methods of use
AUPO118896A0 (en) New use
AU5557698A (en) Novel calpaines, their preparation and use
AU7244094A (en) Lavendamycin analogs, their use and preparation